Haruhiko Hirate
Member of Management BoardMr. Haruhiko Hirate served as Executive Vice President at Dentsu Group Inc. since joining in January 2022 until 2025 and had been its Chief Corporate Affairs Officer since January 2022 until 2024 and serves as its Global Chief Corporate Affairs Officer since 2024. As Chief Corporate Affairs Officer, Dentsu Group Inc., he supports the CEO in planning and executing the Group's business strategy and transformation across the enterprise, especially within Human Resource Management, Corporate Culture and Communications, to help deliver on Dentsu's ambitious goals. He served as Chairman of Juul Labs Japan Company Limited until 2022. Mr. Hirate served as Representative Director of JUUL Labs, Inc. until 2022. Mr. Hirate has experience driving toward solutions in healthcare and the pharmaceutical industry. Mr. Hirate served as Corporate Communications & Public Affairs Officer at Takeda Pharmaceutical Company Limited since October 1, 2014 until 2020. Mr. Hirate served as Global Head of Public Affairs of Takeda Pharmaceutical Company Limited. He served as Senior Vice President of Corporate Communications Department at Takeda Pharmaceutical Company Limited since October 1, 2014. He served as Senior Vice President and Head of North Asia at Takeda Pharmaceutical Company Ltd. Mr. Hirate served as Senior Vice President of International Operations (Asia) at Takeda Pharmaceutical Company Ltd., since August 1, 2010. He served as an Executive Officer of Takeda Pharmaceutical Company Ltd., until July 2010. He served as a Corporate Officer of Takeda Pharmaceutical Company Limited since August 2010. Mr. Hirate served as the President of MSD K.K. from October 1, 2003 to October 2007. He joined Merck from Roche Diagnostics K.K., based in Tokyo, where he served as president since 2000. In 1980, Mr. Hirate began his career at Nissei Sangyo Co., Ltd., a former subsidiary of Hitachi Ltd. and assumed positions of increasing responsibility in the export of Hitachi medical diagnostic equipment to the United States and Europe and sales and marketing in Japan. He is also a Director at the Japan Center for International Exchange and holds professor roles at the Graduate School of Management, GLOBIS University and Keio Business School, Keio University Graduate School. Since 1996, He served as the President of Draeger Japan, a wholly owned subsidiary of Draegerwerk AG, the world-leading German manufacturer of medical equipment and served as head of its Asia Pacific region, since 1999, overseeing three subsidiaries and three joint venture operations, including three manufacturing sites that served more than 17 countries. He served as Representative Senior Managing Director at GlaxoSmithKline in Japan. He served as Representative Director and President at Roche Diagnostics. He served as Representative Director and President of Banyu Pharmaceuticals, the Japanese subsidiary of Merck & Co. He joined Banyu Pharmaceuticals in 2004 from his role as Senior Vice President at Merck & Co. He served as President of North Asia in 2011 and has held Senior Vice President Position at Takeda since 2010. He served as Representative Director of Roche Diagnostics K.K., since 2000. His experience includes executive roles at Global HQs, Region Presidents, Country GM, especially for building new strategies and to execute business transformation. Since 1996, He served as Representative Director of Draeger Japan. Mr. Hirate served as Representative Director of MSD K.K. from October 1, 2003 to October 2007. Mr. Hirate served as Director at the Federation of Pharmaceutical Manufacturers Associations of Japan and Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) Japan. In 2012, he became a member of the Japan Association of Corporate Executives. Mr. Hirate graduated from Keio University in Japan with a Bachelor of Arts degree in Economics in 1980. He received EMBA training from Mannheim University program.
Positions
- Company NameTakeda Pharmaceutical Company LimitedStock CodeTAKPositionMember of Management Board
